1. Nestle FO, Kaplan DH, Barker J.
   Psoriasis
   N Engl J Med.
   2009 Jul 30;361(5):496–509.


2. Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ.
   The genetics of psoriasis.
   Arch Dermatol.
   1994 Feb;130(2):216–24.


3. Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, et al. Genome-wide association study identifies a psoriasis susceptibility locus TRAF3IP2.
   Nat Genet.
   2010 Nov;42(11):991–5.


4. Ellinghaus D, Ellinghaus E, Nair RP, Stuart PE, Esko T, Metspalu A, et al. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci.
   Am J Hum Genet.
   2012 Apr 6;90(4):636–47.


5. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.
   Nat Genet.
   2009 Feb;41(2):199–204.


6. Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, Strange A, Capon F, Spencer CCA, Knight J, Weale ME, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.
   Nat Genet.
   2010 Nov;42(11):985–90.


7. Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE, et al. Genome-wide association analysis identifies three psoriasis susceptibility loci.
   Nat Genet.
   2010 Nov;42(11):1000–4.


8. Sun L-D, Cheng H, Wang Z-X, Zhang A-P, Wang P-G, Xu J-H, et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population.
   Nat Genet.
   2010 Nov;42(11):1005–9.


9. Zhang X-J, Huang W, Yang S, Sun L-D, Zhang F-Y, Zhu Q-X, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.
   Nat Genet.
   2009 Feb;41(2):205–10.


10. De Cid R, Riveira-Munoz E, Zeeuwen PLJM, Robarge J, Liao W, Dannhauser EN, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis.
    Nat Genet.
    2009 Feb;41(2):211–5.


11. Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.
    Nat Genet.
    2012 Dec;44(12):1341–8.


12. Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.
    Am J Hum Genet.
    2011 Sep 9;89(3):432–7.


13. Setta-Kaffetzi N, Simpson MA, Navarini AA, Patel VM, Lu H-C, Allen MH, et al. AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking.
    Am J Hum Genet.
    2014 May 1;94(5):790–7.


14. Viguier M, Guigue P, Pagès C, Smahi A, Bachelez H. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations.
    Ann Intern Med.
    2010 Jul 6;153(1):66–7.


15. Hüffmeier U, Wätzold M, Mohr J, Schön MP, Mössner R. Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.
    Br J Dermatol.
    2014 Jan;170(1):202–4.


16. www.borninbradford.nhs.uk


17. Aasen T and Belmonte JCI. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells.
    Nature protocols 2010;5:371-382.